321 related articles for article (PubMed ID: 17727924)
21. Squamous cell carcinoma antigen serum levels as prognostic parameter in patients with early stage vulvar cancer.
Hefler LA; Sliutz G; Leodolter S; Speiser P; Joura E; Reinthaller A; Kohlberger P
Gynecol Oncol; 2005 Jun; 97(3):904-7. PubMed ID: 15894354
[TBL] [Abstract][Full Text] [Related]
22. SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.
van de Lande J; Davelaar EM; von Mensdorff-Pouilly S; Water TJ; Berkhof J; van Baal WM; Kenemans P; Verheijen RH
Gynecol Oncol; 2009 Jan; 112(1):119-25. PubMed ID: 19007978
[TBL] [Abstract][Full Text] [Related]
23. Squamous cell carcinoma antigen, tumor associated trypsin inhibitor and tissue polypeptide specific antigen in follow up of stage III cervical cancer.
Gitsch G; Kainz C; Joura E; Fröhlich B; Bieglmayr C; Tatra G
Anticancer Res; 1992; 12(4):1247-9. PubMed ID: 1503417
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
25. Study of a new tumor marker, CYFRA 21-1, in squamous cell carcinoma of the cervix, and comparison with squamous cell carcinoma antigen.
Tsai SC; Kao CH; Wang SJ
Neoplasma; 1996; 43(1):27-9. PubMed ID: 8843956
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment serum CYFRA 21-1 level correlates significantly with survival of cervical cancer patients: a multivariate analysis of 506 cases.
Piao X; Kong TW; Chang SJ; Paek J; Chun M; Ryu HS
Gynecol Oncol; 2015 Jul; 138(1):89-93. PubMed ID: 25913134
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of combined examination of pretreatment serum CYFRA21-1 and SCCAg in cervical cancer patients.
Xiong Y; Peng XP; Liang LZ; Zheng M; Li JD
Ai Zheng; 2009 Jan; 28(1):64-7. PubMed ID: 19448420
[TBL] [Abstract][Full Text] [Related]
28. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S
Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
[TBL] [Abstract][Full Text] [Related]
29. Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma.
Nagler RM; Barak M; Peled M; Ben-Aryeh H; Filatov M; Laufer D
Cancer; 1999 Mar; 85(5):1018-25. PubMed ID: 10091783
[TBL] [Abstract][Full Text] [Related]
30. A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer.
Davelaar EM; van de Lande J; von Mensdorff-Pouilly S; Blankenstein MA; Verheijen RH; Kenemans P
Tumour Biol; 2008; 29(1):9-17. PubMed ID: 18497544
[TBL] [Abstract][Full Text] [Related]
31. The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer.
Takeshima N; Hirai Y; Katase K; Yano K; Yamauchi K; Hasumi K
Gynecol Oncol; 1998 Mar; 68(3):263-6. PubMed ID: 9570978
[TBL] [Abstract][Full Text] [Related]
32. [Tumor markers in uterine cancers].
Fukasawa I; Kousaka N; Kun Z; Inaba N
Gan To Kagaku Ryoho; 2002 Feb; 29(2):333-40. PubMed ID: 11865645
[TBL] [Abstract][Full Text] [Related]
33. Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC).
Hung YC; Shiau YC; Chang WC; Kao CH; Lin CC
Neoplasma; 2002; 49(6):415-7. PubMed ID: 12584591
[TBL] [Abstract][Full Text] [Related]
34. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
Geyer H; Schwörer D; Pfleiderer A
Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888
[TBL] [Abstract][Full Text] [Related]
35. Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study.
Niibe Y; Kazumoto T; Toita T; Yamazaki H; Higuchi K; Ii N; Suzuki K; Uno T; Tokumaru S; Takayama M; Sekiguchi K; Matsumoto Y; Michimoto K; Oguchi M; Hayakawa K
Gynecol Oncol; 2006 Nov; 103(2):435-8. PubMed ID: 16677691
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ
Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143
[TBL] [Abstract][Full Text] [Related]
37. [Clinical significance of serum squamous cell carcinoma antigen in the diagnosis, treatment and prognosis of cervical squamous cell carcinoma].
Luan XM; Zhang Y; Wang SZ; Wang N; Li W; Zhang Q; Wei H; Zhang SL
Zhonghua Yi Xue Za Zhi; 2012 May; 92(19):1330-3. PubMed ID: 22883121
[TBL] [Abstract][Full Text] [Related]
38. The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer.
Micke O; Prott FJ; Schäfer U; Tangerding S; Pötter R; Willich N
Anticancer Res; 2000; 20(6D):5113-5. PubMed ID: 11326679
[TBL] [Abstract][Full Text] [Related]
39. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix.
Ngan HY; Cheng GT; Yeung WS; Wong LC; Ma HK
Gynecol Oncol; 1994 Jan; 52(1):63-8. PubMed ID: 8307503
[TBL] [Abstract][Full Text] [Related]
40. Analysis of serum CYFRA 21-1 concentrations in patients with esophageal cancer.
Brockmann JG; St Nottberg H; Glodny B; Sprakel B; Senninger N
Anticancer Res; 2000; 20(6D):4899-904. PubMed ID: 11332443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]